HCPConnect

For HCPsIntended for HCPs.
POWDERUnfinished Product

FDA Drug Reference

Topiramate

Dosage Form

POWDER

Route

Not specified

NDC

10695-311

This page summarizes official FDA drug label records for professional reference. Verify prescribing decisions against the complete current label and institutional policy.

Label Record Status

Source: U.S. Food and Drug Administration label records. Listing expiration: Date unavailable

Clinical Pharmacology

Indications & Usage

Topiramate is listed as a POWDER formulation in the POWDER category. Consult official FDA labeling for full prescribing information.

Administration Context

Topiramate is administered via the appropriate route as a POWDER.

Administration Protocol

Prescribing Information

Refer to official FDA labeling or institutional protocols for complete dosage and administration instructions.

Safety Profile

Contraindications & Warnings

Consult the official FDA-approved labeling for complete contraindications, warnings, precautions, and patient-specific safety information.

National Drug Registry

Product and label metadata.

Marketing Category

BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

Route of Administration

Not specified

National Drug Code

10695-311

Manufacturer / Labeler

Willow Birch Pharma, Inc.

Dosage Form

POWDER

Strength

See labeling

Application Number

N/A

SPL Identifier

3ce1e58d-edff-037e-e063-6394a90a1d10

Related Resource

Vaccine Safety Information

Access evidence-based safety data and clinical guidance from global health resources.

View Resource